Skip to main content

Zoion Pharma Inc.

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Jun 28, 2012
Award amount: 
Organization name: 
Zoion Pharma Inc.
Principal Investigator: 
Mossinghoff, Gregory J.
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Research Triangle

Zoion Pharmaceuticals will develop innovative or overlooked drugs for prevalent veterinary disorders. Regulatory requirements are less demanding, decreasing costs and risks. Zoion's lead product, ZP-1 (P-1046), to be licensed from Parion, is a novel epithelial sodium channel blocker (ENaC) compound to treat canine keratoconjunctivitis (KCS) or dry eye.

Fiscal year: